Tuesday, June 2, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Trends

Data & Individuals

Daily Remedy by Daily Remedy
August 30, 2021
in Trends
0

“I distrust the medical facts”, American philosopher Ralph Waldo Emerson wrote when criticizing nineteenth-century healthcare’s tendency towards Reductionism, a belief that perceives a complex system to be the sum of its parts.

Yet Emerson’s words did little to curb the tide, and modern healthcare is now fully immersed in reductionist belief, to where we use data to predict patient behavior, and to price insurance premiums and clinical services accordingly.

Our world has become so digitized that we assume the future of healthcare means incorporating more technology into it. However, just because a little of something is good, it does not automatically follow that a lot of something is better.

Technology, as with most things in life, is best in moderation. And when taken to its extreme, transforms into something entirely different.

Technology epitomizes the modern reductionist ethos in healthcare. Technologists believe we can use data to solve healthcare problems, because they believe we are defined by our data. That any behavior, no matter how rational or irrational, how stereotypical or individualized, can be understood through data or multiple data sets.

We diagnose and monitor diabetes through HbA1c levels, which measure the average blood glucose. We make clinical decisions on hypertension management based on a patient’s blood pressure. And we measure success through quantified outcomes – even quantifying the inherently qualitative, like patient satisfaction.

While data standardize the quality of care, it reduces patient care to the rubric of standardization. Eventually data define the patient. In other words, we are defined by our component parts.

When taken to its logical extreme, data can be used to influence as much as diagnose patient behavior.

Data can be used to price out rolling tax rates based upon a patient’s body mass index (BMI). Those with a higher BMI, the obese, might then pay a higher tax on unhealthy foods like ice cream and red meats.

Data can analyze a person’s purchasing history and credit rating to determine the capacity to pay hospital bills. And preemptively let hospitals know how much of the cost of care a patient can realistically pay.

Data can diagnose, manage, and treat medical conditions. Just like it can predict, stratify, and analyze patient behaviors.

Eventually we will have to reconcile the data and the individual, and determine how much of the data represent who we are as individuals.

Are we the cumulative sum of our medical data?

Can we be defined by a medical decision?

In Florida, physicians walked out on a hospital system and refused to treat unvaccinated patients, an effort for which they were lauded across media outlets.

But is it ethical to judge a patient worthy or unworthy of treatment based upon one medical decision – to be vaccinated? Yes, the data suggest unvaccinated patients have more COVID-19 related complications and can place a greater burden on the healthcare system.

But no medical ethicist would advise refusing treatment on that basis. And here is where we find limits on the value of data.

Data can do many things for healthcare, but it cannot define fundamental clinical decisions. It should always be used as a tool to support physicians and nurses, as a complement to patient care. If we depend upon data to make fundamental clinical decisions, then we lose individual patient autonomy.

Eventually we will justify rolling taxes on consumer goods based upon clinical conditions. It is easy to say a person with a family history of lung cancer should pay more for cigarettes if he or she cannot quit smoking despite the prevalent medical risk. But such logic becomes less palatable when we are asked to pay a higher tax for pumpkin pie in autumn because we gained weight during the pandemic.

Healthcare was never intended to be fully reductionist, nor was the data ever intended to supersede the individual.

In our quest to improve healthcare, we have unleashed data across all facets of patient care. In most instances it has helped, which has prompted calls for more data.

But anything taken to an extreme no longer possesses its original value. And if we overwhelm healthcare through an influx of data, then we will lose the original value of data.

Emerson wrote, “I distrust the medical facts”, despite relying heavily on facts throughout his prodigious writing career. We too must find a balance between relying on data and maintaining a healthy skepticism of it.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • A man wearing a suit raising a judge's gavel beside a small model hospital building on a desk in a bright office.

    When Hospitals Can Be Liable for Abusive Providers

    0 shares
    Share 0 Tweet 0
  • Observations From the Rx & Illicit Drug Summit

    0 shares
    Share 0 Tweet 0
  • Case Analysis of Dr. Ball

    1 shares
    Share 0 Tweet 0
  • Retatrutide: The Weight Loss Drug Everyone Wants—But Can’t Officially Get

    1 shares
    Share 0 Tweet 0
  • Employers Don’t Really Care About Your Mental Health

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy